← Back to Search

QL Block for Postoperative Pain in Hip Surgery

Q: What is the aggregate figure of people enrolled in this experiment?

<p>Affirmative. On clinicaltrials.gov, the available information indicates that this medical trial is currently looking for eligible patients; it was first posted on March 29th 2022 and most recently updated on April 5th 2022. The study needs to enroll 80 participants from 1 site.</p>

Q: Is this experiment recruiting participants at present?

<p>Confirmed. Evidently, this clinical trial is still searching for participants and was originally posted on March 29th 2022. The last update to the listing came on April 5th of that same year and 80 individuals are needed at one site.</p>

Phase < 1

Recruiting

Led By Pamela Chia, MD

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult subjects undergoing elective primary total hip arthroplasty

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 48 hrs post op

Awards & highlights

Study Summary

This trial will assess whether the quadratus lumborum (QL) block, a nerve block injection that numbs pain in the lower abdomen, is an effective method of pain relief for patients undergoing a total hip arthroplasty. Patients will be randomized to receive the QL nerve block with either saline or ropivacaine, and postoperative outcomes will be assessed for pain, opioid use, length of hospital stay, and patient satisfaction.

Who is the study for?

This trial is for adults having elective primary total hip arthroplasty. It's not suitable for those under 18, with allergies to local anesthetics, peripheral neuropathy, long-term opioid use, or conditions that contraindicate spinal and regional anesthesia like coagulopathy or site infections.Check my eligibility

What is being tested?

The study tests the effectiveness of Quadratus Lumborum (QL) blocks in managing pain after hip replacement surgery. Participants will be randomly assigned to receive either the QL block (active comparator) or a placebo.See study design

What are the potential side effects?

Potential side effects may include discomfort at the injection site, possible nerve damage due to needle placement, allergic reactions to the anesthetic used in QL blocks, and inadequate pain relief.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult scheduled for my first total hip replacement surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 48 hrs post op

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 48 hrs post op

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 48 hrs post op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain score

Secondary outcome measures

Ambulation distance

Length of hospital stay

Opioid usage

+3 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Intervention GroupActive Control1 Intervention

Quadratus lumborum nerve block with 0.25% ropivacaine

Group II: Control GroupPlacebo Group1 Intervention

Quadratus lumborum nerve block with saline

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,530 Previous Clinical Trials

10,264,628 Total Patients Enrolled

1 Trials studying Postoperative Pain

102 Patients Enrolled for Postoperative Pain

Pamela Chia, MDPrincipal InvestigatorUniversity of California, Los Angeles

Eva Boyd, MDPrincipal InvestigatorUniversity of California, Los Angeles

Media Library

Intervention Group Clinical Trial Eligibility Overview. Trial Name: NCT05247255 — Phase < 1

Postoperative Pain Research Study Groups: Intervention Group, Control Group

Postoperative Pain Clinical Trial 2023: Intervention Group Highlights & Side Effects. Trial Name: NCT05247255 — Phase < 1

Intervention Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05247255 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate figure of people enrolled in this experiment?

"Affirmative. On clinicaltrials.gov, the available information indicates that this medical trial is currently looking for eligible patients; it was first posted on March 29th 2022 and most recently updated on April 5th 2022. The study needs to enroll 80 participants from 1 site."

Answered by AI

Is this experiment recruiting participants at present?

"Confirmed. Evidently, this clinical trial is still searching for participants and was originally posted on March 29th 2022. The last update to the listing came on April 5th of that same year and 80 individuals are needed at one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quadratus Lumborum Block for Total Hip Arthroplasty

Pamela Chia 2022. "Quadratus Lumborum Block for Total Hip Arthroplasty". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05247255.